We confirm with the model that the anti-CTLA4 treatments allow clonal expansion in the lymph nodes, but this is not enough for an efficient immune response, because differentiation into specific T effectors is blocked by immune checkpoints in the tumour bed. This evidence concerns the gene CTLA4 and neoplasm.